Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety

Nature Genetics

Volumn 23, Issue 1, 1999, Pages 99-103

  Tronche, François ^a   Kellendonk, Christoph ^a   Kretz, Oliver ^c   Gass, Peter ^a   Anlag, Katrin ^a   Orban, Paul C ^b   Bock, Rudolf ^c   Klein, Rüdiger ^b   Schütz, Günther ^a  

^a Molecular Biology of the Cell I   (Germany)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; COGNITION; CONTROLLED STUDY; CUSHING DISEASE; EMBRYO; EMOTION; GENE TARGETING; GENETIC TRANSFECTION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR GENE; RECEPTOR INTRINSIC ACTIVITY; STEM CELL; TRANSCRIPTION REGULATION;

ADRENAL GLANDS; AGE FACTORS; ANIMALS; ANXIETY; BRAIN; CORTICOSTERONE; CUSHING SYNDROME; DISEASE MODELS, ANIMAL; DNA NUCLEOTIDYLTRANSFERASES; INTEGRASES; KIDNEY; MICE; MICE, TRANSGENIC; MUTAGENESIS; OBESITY; OSTEOPOROSIS; RECEPTORS, GLUCOCORTICOID; RECOMBINASES; TIME FACTORS; TRANSFECTION;

ANIMALIA;

EID: 0032842478     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/12703     Document Type: Article

References (30)

1. Tronche, F., Kellendonk, C., Reichardt H.M. & Schütz, G. Genetic dissection of glucocorticoid receptor function in mice. Curr. Opin. Genet. Dev. 8, 532-538 (1998).
2. Reichardt, H.M. et al. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93, 531-541 (1998).
3. McEwen, B.S. & Sapolsky, R.M. Stress and cognitive function. Curr. Opin. Neurobiol. 5, 205-216 (1995).
4. De Kloet, E.R., Vreugdenhil, E., Oitzl, M.S. & Joels, M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 19, 269-301 (1998).
5. Piazza, P.V. & Le Moal, M. Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu. Rev. Pharmacol. Toxicol. 36, 359-378 (1996).
6. Cole, T.J. et al. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 9, 1608-1621 (1995).
7. Gu, H., Marth, J.D., Orban, P.C., Mossmann, H. & Rajewsky, K. Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting. Science 265, 103-106 (1994).
8. Zimmerman, L. et al. Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors. Neuron 12, 11-24 (1994).
9. Miller, W.L. & Blake Tyrrel, J. in The Adrenal Cortex (eds Felig, P., Baxter, J.D. & Frohman, L.A.) 555-711 (McGraw-Hill, New York, 1995).
10. Fink, G. in Mechanism of Negative and Positive Feedback of Steroids in the Hypothalamic-Pituitary System (eds Bittar, E.E. & Bittar, N.) 30-100 (JAI-press, Greenwich, 1997).
11. Heym, C. Immunocytochemical correlates of an extrapituitary adrenocortical regulation in man. Histol. Histopathol. 12, 567-581 (1997).
12. Gagner, J.P. & Drouin, J. Tissue-specific regulation of pituitary proopiomelanocortin gene transcription by corticotropin-releasing hormone, 3′,5′-cyclic adenosine monophosphate, and glucocorticoids. Mol. Endocrinol. 1, 677-682 (1987).
13. Shipston, M.J. Mechanism(s) of early glucocorticoid inhibition of adrenocorticotropin secretion from anterior pituitary corticotropes. Trends Endocrinol. Metab. 6, 261-266 (1995).
14. Birnberg, N.C., Lissitzky, J.C., Hinman, M. & Herbert, E. Glucocorticoids regulate proopiomelanocortin gene expression in vivo at the levels of transcription and secretion. Proc. Natl Acad. Sci. USA 80, 6982-6986 (1983).
15. van Haarst, A.D., Oitzl, M.S., Workel, J.O. & de Kloet, E.R. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity. Endocrinology 137, 4935-4943 (1996).
16. Gold, P.W. et al. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. N. Engl. J. Med. 314, 1329-1335 (1986).
17. Holsboer, F. & Barden, N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr. Rev. 17, 187-205 (1996).
18. Korte, S.M., De Kloet, E.R., Buwalda, B., Bouman, S.D. & Bohus, B. Antisense to the glucocorticoid receptor in hippocampal dentate gyrus reduces immobility in forced swim test. Eur. J. Pharmacol. 301, 19-25 (1996).
19. Jefferys, D. & Funder, J.W. Glucocorticoids, adrenal medullary opioids, and the retention of a behavioral response after stress. Endocrinology 121, 1006-1009 (1987).
20. Shepherd, J.K., Grewal, S.S., Fletcher, A., Bill, D.J. & Dourish, C.T. Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety. Psychopharmacology (Berl) 116, 56-64 (1994).
21. Andreatini, R. & Leite, J.R. The effect of corticosterone in rats submitted to the elevated plus-maze and to to pentylenetetrazol-induced convulsions. Prog. Neuropsychopharmacol. Biol. Psychiatry 18, 1333-1347 (1994).
22. Britton, K.T., Lee, G., Dana, R., Risch, S.C. & Koob, G.F. Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone. Life Sci. 39, 1281-1286 (1986).
23. Korte, S.M., de Boer, S.F., de Kloet, E.R. & Bohus, B. Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze. Psychoneuroendocrinology 20, 385-394 (1995).
24. Smythe, J.W., Murphy, D., Timothy, C. & Costall, B. Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior in rats. Pharmacol. Biochem. Behav. 56, 507-513 (1997).
25. Pepin, M.C., Pothier, F. & Barden, N. Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature 355, 725-728 (1992).
26. Montkowski, A. et al. Long-term antidepressanttreatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function. J. Neuroendocrinol. 7, 841-845 (1995).
27. Stenzel Poore, M.P., Heinrichs, S.C., Rivest, S., Koob, G.F. & Vale, W.W. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J. Neurosci. 14, 2579-2584 (1994).
28. Timpl, P. et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nature Genet. 19, 162-166 (1998).
29. Smith, G.W. et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20, 1093-1102 (1998).
30. Sapolsky, R.M. Why stress is bad for your brain. Science 273, 749-750 (1996).